CTRI/2021/05/033702尚未招募不适用
Association of Cardiovascular risk estimate with degree of Atherosclerosis in patients with Type 2 Diabetes Mellitus
Dr Pamarthi Meghavarna1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年5月26日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- To estimate the 10 years risk of development of cardiovascular disease in diabetic patients using different risk engines.
研究概览
简要总结
This study is a hospital based , cross- sectional, observational study done in type 2 diabetes Mellitus patients, to estimate 10 years cardiovascular risk by using different risk engines UKPDS,FRS,Q RISK and ASCVD. To measure the Carotid Intima Media Thickness by ultrasonography in diabetic patients and to correlate between 10 years cardiovascular risk using different risk engines with CIMT, so that morbidity and mortality due to diabetes in long term can be reduced.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 41.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of Type 2 Diabetes Mellitus with age above 40 years in whom CIMT is done as standard of care by the Department of Radiology will be included in the study.
排除标准
- •Ischemic heart disease on treatment, Acute coronary syndrome, Post Percutaneous Transluminal Coronary Angioplasty, Post Coronary Artery Bypass Grafting, Dyslipedemia on treatment, CVA, Peripheral Vascular Disease, CKD and Connective tissue disorders.
结局指标
主要结局
To estimate the 10 years risk of development of cardiovascular disease in diabetic patients using different risk engines.
时间窗: 2years
次要结局
- To correlate between 10 years cardiovascular risk using different risk engines with Carotid Intima Media Thickness, so that morbidity and mortality due to diabetes in long term can be reduced.(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
Available
不适用
A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic SyndromeDiabetesCVDNCT00965315National Taiwan University Hospital
已完成
不适用
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular OutcomesDiabetes Mellitus, Type 2NCT03993132Boehringer Ingelheim26,774
已完成
不适用
Therapeutic Approach of Cardiovascular Risk Factors in T2DM by GenderCardiovascular Risk FactorGenderType 2 DiabetesNCT04653805Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina300,000
Unknown
不适用
Vascular and Metabolic Changes in Postmenopausal DiabeticsDiabete Type 2NCT03273738Assiut University100
Unknown
2 期
Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)Atherosclerotic Cardiovascular DiseaseSubclinical Disease and/or SyndromeNCT01353066Hospital Clinic of Barcelona240